Influence of Vaginal Lactoferrin on Amniotic Fluid Cytokines to Avoid Pregnancy Complications

• Status: Completed
• Trial end date: 2012-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

Objective: To evaluate the influence of vaginal Lactoferrin administration on amniotic fluid concentration of 47 cytokines, chemokines and growth factors.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Università degli Studi di Ferrara
• Treatments: Lactoferrin

Criteria

Inclusion Criteria:

• singleton physiological pregnancy;

• maternal age as the only indication to foetal karyotyping

Exclusion Criteria:

• assumption of drugs interfering with the immune system;

• previous miscarriages;

• pregnancy at risk for maternal or foetal disease;

• lactose intolerance.